Related Experiment Video
Updated: Jul 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal
1Head and Neck Institute, The Cleveland Clinic, Cleveland, OH 44195, USA. benninm@ccf.org
Objective:
Acute bacterial rhinosinusitis and acute otitis media are two of the most common respiratory tract infections. The common pathogenic bacteria associated with these infections are Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus. With the recent widespread use of pneumococcal conjugate vaccine, there is evidence that there is a shift of both the pneumococcal serotypes and the distribution of pathogenic bacteria. The purpose of this article was to investigate whether the literature supports changes in pathogenicity of acute bacterial rhinosinusitis and otitis media after widespread use of conjugate pneumococcal vaccine.
Data Sources:
MEDLINE search of the literature was performed between 1995 and 2007.
Review Methods:
Literature review of changes in distribution of pathogens, resistance rates, and pneumococcal serotype changes before and after widespread use of conjugate pneumococcal vaccine.
Results:
There is evidence that the distribution of pneumococcal serotypes has changed after the widespread use of conjugate pneumococcal vaccine. There appears to be both less invasive and noninvasive pneumococcal disease and with childhood immunization there also appears to be a protective effect on adults (herd immunity). Increases in nonvaccine serotypes, some with high levels of resistance are being identified in some communities. There is also growing evidence that there may be an increasing prevalence of Haemophilus influenzae in these infections.
Conclusions:
Widespread use of conjugate pneumococcal vaccine has led to decreasing incidence of pneumococcal otitis media and likely also acute bacterial rhinosinusitis, which may have implications for treatment recommendations for these infections.
Insights
The pneumococcal conjugate vaccine has reduced the incidence of pneumococcal otitis media and acute bacterial rhinosinusitis. However, shifts in pneumococcal serotypes and increasing prevalence of Haemophilus influenzae may impact future treatment strategies.
Area of Science:
- Infectious Diseases
- Vaccinology
- Microbiology
Background:
- Acute bacterial rhinosinusitis and acute otitis media are common infections.
- Key pathogens include Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus.
- Widespread pneumococcal conjugate vaccine use may alter pathogen distribution and serotypes.
Purpose of the Study:
- To evaluate literature supporting changes in pathogenicity of these infections post-vaccine introduction.
- To assess the impact of conjugate pneumococcal vaccine on bacterial distribution and resistance patterns.
Main Methods:
- MEDLINE literature search conducted from 1995 to 2007.
- Review focused on pathogen distribution, resistance rates, and pneumococcal serotype shifts before and after vaccine implementation.
Main Results:
- Pneumococcal serotype distribution has changed, with a decrease in vaccine-type disease and evidence of herd immunity.
- Increases in non-vaccine serotypes, some with high resistance, are noted.
- Growing evidence suggests an increasing prevalence of Haemophilus influenzae in these infections.
Conclusions:
- Conjugate pneumococcal vaccine use has decreased the incidence of pneumococcal otitis media and likely acute bacterial rhinosinusitis.
- These shifts may necessitate adjustments in current treatment recommendations for these common infections.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Mechanism of Antibiotic Resistance in MRSA
Microbiota of the Respiratory Tract
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...